Lost in application: Measuring hypoxia for radiotherapy optimisation.

Area of Science:

• Oncology
• Radiation Oncology
• Molecular Biology

Background:

• Hypoxia (low oxygen) is a critical factor in tumor progression and metastasis.
• Radiotherapy effectiveness is significantly impacted by tumor hypoxia.
• Despite evidence, hypoxia-targeting treatments have faced challenges in clinical application.

Purpose of the Study:

• To review recent advancements in hypoxia gene expression signatures.
• To highlight progress and challenges in applying these signatures for personalized radiotherapy.
• To establish a roadmap for clinical implementation of hypoxia biomarkers.

Main Methods:

• Review of current literature on hypoxia research and gene expression signatures.
• Analysis of existing clinical trial data, including transcriptomic information.
• Discussion of challenges in biomarker development and clinical translation.

Main Results:

• Hypoxia-targeting treatments with radiotherapy show improved locoregional control and survival.
• Gene expression signatures overcome limitations of previous hypoxia biomarkers.
• There is a strong evidence base for personalizing radiotherapy based on hypoxia status.

Conclusions:

• Personalizing radiotherapy using hypoxia status is supported by strong evidence.
• Hypoxia gene expression signatures are a promising tool for biologically optimized radiotherapy.
• Further development and standardization are needed for clinical application of hypoxia biomarkers.